CTNM SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 30, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 5, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 30, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Contineum Therapeutics Reports Third-Quarter 2026 Financial Results and Provides Corporate Update

Nov 3, 2026

8-K

Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 in Major Depressive Disorder

Sep 14, 2026

8-K

Contineum Therapeutics Reports Second-Quarter 2026 Financial Results and Affirms Clinical Milestones

Jul 30, 2026

8-K

Contineum Therapeutics Corporate Overview: PIPE-791 Development for IPF

Jul 13, 2026

8-K

Contineum Therapeutics, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 26, 2026

8-K

Contineum Therapeutics Reports First-Quarter 2026 Financial Results and Clinical Progress

May 5, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

March 2026 ATM | Offering amount: $100,000,000 | Bank: Leerink Partners LLC

Mar 5, 2026

424B5

REGISTERED OFFERING

Dec 12, 2025

424B5

PENDING FIXED PRICE OFFERING | Offering amount: $75,000,000 | Bank: Goldman Sachs & Co. LLC, Leerink Partners, Stifel, RBC Capital Markets, William Blair

Dec 11, 2025

424B4

OFFERING | Shares amount: 6,875,000 | Share price: $16.00 | Offering amount: $110,000,000.00

Apr 5, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 5, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 14, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

May 14, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 6, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 9, 2024

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Apr 2, 2024

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

May 27, 2025

CORRESP

Form CORRESP - Correspondence

May 21, 2025

LETTER

Form UPLOAD - SEC-generated letter

May 20, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 5, 2024

CORRESP

Form CORRESP - Correspondence

Apr 2, 2024

CORRESP

Form CORRESP - Correspondence

Apr 2, 2024

Contineum Therapeutics, Inc. CTNM · SEC Filings